Details for 2012700390

Up to date per 01.04.2026

Actions

Title / Product Name

OXAZIN-DERIVATE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012700390

EP Publication Number

2663561

E-Number

781118

Language

PCT Number

EP12050395

Publication Date

20.11.2013 A

16.03.2016 B1

Registration Date

16.03.2016

AT Publication Date

15.04.2016

Application Date

11.01.2012

Registration Number

Priorities

13.01.2011

DE00772011

14.09.2011

201161534591 P

IPC

C07D 413/14 20060101AFI20150513BHEP

Maximum Duration of Protection

11.01.2032

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

BADIGER, SangameshAurigene Discovery Technologies Limited 39-40 KIADB Industrial Area Electronic City Phase II Hosur Road Bangalore Karnataka 560 100IN

CHEBROLU, MuraliAurigene Discovery Technologies Limited 39-40 KIADB Industrial Area Electronic City Phase II Hosur Road Bangalore Karnataka 560 100IN

HURTH, KonstanzeNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

JACQUIER, SébastienNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

LUEOEND, Rainer MartinNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

MACHAUER, RainerNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

RUEEGER, HeinrichNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

TINTELNOT-BLOMLEY, MarinaNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

VEENSTRA, Siem JacobNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

VOEGTLE, MarkusNovartis Pharma AG Werk Klybeck Postfach CH-4002 BaselCH

Information about Fees